Adrenaline | Noradrenaline | |||||
---|---|---|---|---|---|---|
B* | 95% CI of B | p Value | B* | 95% CI of B | p value | |
Gestational age (p = 0.81 and 0.67), baseline adrenaline and noradrenaline concentrations (ln transformed) (p = 0.21 and 0.13), and prenatal corticosteroid use (only in adrenaline analyses; p = 0.42) were excluded from the analysis (p>0.1) by using the backward method. p Values in bold are significant. | ||||||
*Unstandardised regression coefficients. | ||||||
†The mean amount of extra morphine used for each infant in μg/kg per hour during study. | ||||||
‡Birth weight was compared with normal mean birth weight for each patient, as a measure of small for gestational age infants. | ||||||
Condition (placebo/morphine) | −0.079 | −0.20 to 0.037 | 0.18 | −0.25 | −0.48 to −0.027 | 0.029 |
Amount of extra morphine† | −0.0091 | −0.028 to 0.010 | 0.34 | −0.0081 | −0.046 to 0.030 | 0.67 |
Deviation birth weight‡ | −0.039 | −0.077 to 0.001 | 0.046 | −0.091 | −0.17 to −0.015 | 0.019 |
Dopamine infusion | 0.23 | 0.082 to 0.37 | 0.003 | 0.42 | 0.13 to 0.71 | 0.005 |
Prenatal corticosteroids | 0.41 | 0.17 to 0.65 | 0.001 | |||
Participating centre | −0.11 | −0.24 to 0.013 | 0.078 | −0.23 | −0.47 to 0.004 | 0.054 |
R = 0.50, Radj2 = 0.20 | R = 0.64, Radj2 = 0.36 |